PSMD14 and neoplasm: Spearman correlation analysis revealed a significant negative correlation between PSMD14 expression and Tumor Immunity Cycle (TIP) (31), scores in LUAD (Figure 3C), suggesting that elevated PSMD14 levels may impair anti-tumor immune activity.